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Malaria is a major health problem not only in Indonesia, but also the world.  Incidence of anti malarial 
drug resistance has been found, and one of the possible cause is genetic factors.  The changes that occur in the 
Plasmodium falciparum gene cause genetic variations that lead to resistance for treatment.  There is a gene with 
high polymorphism that can be used as a gene marker of genetic variation in Plasmodium falciparum. 
Objective  
This study aim to identification of Plasmodium falciparum merozoit surface protein-1 (PFMSP-1) gene 
from malaria patients in Puskesmas Hanura, Pesawaran, Lampung. 
Methods 
Descriptive method with morbidity survey approach is used in this study. There are total 23 biological 
material stored that had been taken in 2016 from malaria patient in Puskesmas Hanura, Pesawaran, Lampung, by 
consecutive sampling. Identification of genetic variance of the Plasmodium falciparum gene was performed by 
nested PCR at Medical Faculty Biomolecular Laboratory of Lampung University. The results of this study were 
processed using a computer software. 
Results 
There are 23 samples that amplified following nested PCR for Plasmodium falciparum Merozoit Surface 
Protein-1 (PFMSP-1) gene target. In all samples studied, there are PFMSP-1 gene with six variations base pair 
length range from 200 to 1000 bp. 
Conclusions 
The study has successfully amplified PFMSP-1 gene from individual’s blood sample infected by Malaria 
in Puskesmas Hanura, Pesawaran, Lampung. 
 




Malaria is one of the mosquito-borne disease that remains a major world health problem. 
In 2015, there are 212 million new cases worldwide. Estimated about 429.000 deaths in 2015, 
of which 92% were in WHO Afican region, 6% were in WHO South-East Asian region, and 
followed by 3% in WHO eastern Mediterranean region. Incidence rate of Malaria from 2010 to 
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2015 has decreased about 21%.1  Malaria is a burden that causing health problem in tropical 
region, specifically Indonesia. Annual Parasite Incidence (API) is a number of microscopically 
confirmed malaria cases detected during one year per 1000 individuals. In 2015, highest API 
were found in Papua, followed by West Papua, East Nusa Tenggara, Maluku, North Maluku, 
etc. Lampung is one of the endemic region of Malaria sat on 12th highest API provinces in 
Indonesia.2 Lampung’s Health Department stated that there are 26.722 cases of malaria with 
two deaths caused by Malaria occur in 2015. Highest Lampung’s API were in Pesawaran 
district (6.36), followed by West Pesisir District (3.47) and Bandar Lampung (0,58).3  
Therapy given to patient with malaria are aims to kill and reduce parasitemia in the 
patient's body. This therapy uses anti-malarial drugs, but in some areas, resistance has been 
found to these treatments.4 The cause of resistance has begun to be widely studied and most 
studies say genetic factors are commonly cause the resistance. Genetically, a change in DNA 
structure can occur due to environmental stress or mutations. These changes of DNA 
stimulating changes of characteristic in previous genes, resulting in various genetic variations. 
In the case of malaria, the changes of DNA causing anti-malaria drugs unable kill the parasite, 
so that treatment is not successful 5,6. 
In Plasmodium falciparum, there are genes used as a marker for describing many 
biological processes like treatment failure, genetic diversity, transmition rate, multicon or 
multigenotip infection and immune response. Genes used as a marker for genetic diversity has 
the highest polymorphism level. There are three blocks of gene’s location in Plasmodium 
falciparum which are conserved block, semiconserved block and block that placed in between. 
Gene that located in conserved and semiconserved block is the gene that its presences is 
preserved by these creatures, while the genes that located in between has the highest 
polymorphism level because of genetic mutation that increase genetic variation. One of the 
genes that have a high level of polymorphism in Plasmodium falciparum is the Plasmodium 
falciparum Merozoit Surface Protein-1 (PFMSP-1) gene. Based on several previous studies, the 
dominant allele of the PFMSP-1 gene found in Asia including Indonesia is MAD20.5,7,8 Based 
on this, this study will identify one gene, the PFMSP-1 gene specific to the MAD20 allele 
patient with malaria at Puksesmas (Central of Public Health Services) Hanura, Pesawaran, 
Lampung. 
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Methods 
This study is a quantitative research with descriptive survey method. The approach taken 
in this study is a morbidity survey to see the distribution of Plasmodium falciparum Merozoit 
Surface Protein-1 (PFMSP-1) gen. Subject of the research was biological material stored in the 
form of blood patient with malaria in the Puskesmas (Central of Public Health Services) Hanura 
area, Pesawaran, Lampung in 2016. Sampling began with collection data of patient with malaria 
in Puskesmas Hanura, Pesawaran, Lampung. Patient with malaria who have been received 
treatment are then given an explanation of the study and continued with informed consent. 
Patients who agreed to participate then would be taken blood test directly at the Puskesmas 
Hanura, Pesawaran, Lampung. The blood then placed in edta tube and each sample is given a 
sequential code label. Blood next would be sent to Parasitology Laboratory of Lampung 
University using a cool box which is stored in a refrigerator. This study was conducted at the 
Biomolecular Laboratory of Lampung University in August - December 2017. 
Sample selection was using consecutive sampling which fit inclusion and exclusion 
criteria that have been determined. The inclusion criteria followed, sample can be used in PCR 
test and sample is sufficient in volume. Biological material stored with poor storage will be 
excluded. There are total 23 samples collected in this study. 
This research was conducted in three stages, First DNA extraction, second DNA 
amplification (Nested PCR) and third electrophoresis. In the first stage, the blood patient with 
malaria was extracted using QIAamp® DNA Mini Kit (Qiagen).9 The DNA then would be 
amplified. 
At the amplification stage the method used was nested PCR, which is carried out 
amplification process twice of sample under the study. Amplification stage used KAPA HiFi 
HotStart PCR Kit (Kapabiosystem)10 and MyFi™ DNA Polymerase (Bioline)11. The instrument 
used in the amplification stage is Rotor-Gene® Q (Qiagen). The first stage amplification target 
is the PFMSP-1 gene and second amplification was MAD20 allele of the PFMSP-1 gene. The 
primers used in this study are accordant with primers published by Snounou and Färnet 
described in table one. The PCR conditions were 5 min at 95˚C for predenaturation; 1 min at 
94˚C for denturation; 2 min at 58˚C for anneling in first amplification and 2 min at 61˚C for 
anneling in second amplification; 2 min at 72˚C for extension; and 5 min at 72˚C for final 
extention.12 During the PCR process, the condition was repeated 25 cycles (first amplification) 
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and 30 cycles (second amplification) with the KAPA HiFi HotStart PCR Kit (Kapabiosystem). 
In MyFi ™ DNA Polymerase (Bioline) it takes 30 cycles for both the first and the second 
amplification. 
 
Table 1. Oligonucleated sequences (Primer) 
Reaction Base Sequences 
First reaction 
PFMSP-1 M1-OF 5′- CTAGAAGCTTTAGAAGATGCAGTATTG -3′ 
 M1-OR 5′- CTTAAATAGTATTCTAATTCAAGTGGATCA-3′ 
Second reaction 
MAD20 M1-MF 5′-AAATGAAGGAACAAGTGGAACAGCTGTTAC-3′  
 M1-MR 5′-ATCTGAAGGATTTGTACGTCTTGAATTACC -3′  
Source:  (Snounou dan Färnet, 2013). 
  
The amplification products were analyzed by electrophoresis on a 1% agarose gel in 100 
V, 50 Watt and 250 mAh for 55 minutes. The result then would be read under UV 
transilluminator. The identified PFMSP-1 gene is characterized by the presence of a band when 
reading process on the UV transilluminator. Genetic variations can be identified from the base 
length of each band found. The positive genetic variation is indicated by founding variety in 
the base length of each band. 
The results of this study are numerical data (ratios) in the form of base lengths of each 
identified band. The distribution of PFMSP-1 gene was analyzed used computer software. 
 
Result 
There are total 23 samples of biological material stored successfully extracted resulting 
200 μl of volume for each sample. Those result then amplified following nested PCR methods. 
Identification of PFMSP-1 gene’s base pairs length are used by using visualizations of the 
electrophoresis result under UV transiluminator. Visualizations results are shown in figure one. 
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Figure 1. Electrophoresis result 
 
Figure one is a visualization of a sample that has been on PCR. Band on each sample 
were visualized is MAD20 alleles of genes PFMSP-1 with a base pairs length corresponds to 
the length of DNA markers used. Figure one show that there are band on sample number 19 
(200 bp), 20 (200 bp, 300 bp, 1000 bp), 21 (200 bp, 400 bp), 22 (200 bp, 400 bp, 1000 bp), dan 
23 (200 bp). There are 28 bands identified out of 23 total samples with more than one band can 
identified in one. Four variaton of base pairs length were identified within range of 200-1000 
bp, the majority of base pairs is 200 bp. Data base distribution that has been identified are 
explained in table three. 
 
Table 3. Base Pairs Length Distribution  
Base pairs length Total Band 
200 bp 20 
300 bp 4 
400 bp 2 




This study has successfully amplified PFMSP-1 gene (MAD20) from individual’s blood 
sample infected by Malaria in Puskesmas Hanura, Pesawaran, Lampung.  The PFMSP-1 gene 
in this study was positive found genetic variations with the results of four base pairs length 
variations identified in the range of 200-1000 bp, with 200 bp become the most identified. This 
result is match with previous study conducted on four different hospital in South Sumaterea. 
Those study identified PFMSP-1 gene with nine gene’s variations range from 175-600 bp.13 
There are many Indonesia’s provinces has been identified PFMSP-1 gene besides South 
Sumatera. Another study in West Sumatera, shows PFMSP-1 gene’s (MAD20) base pairs 
length variation range from 110-360 bp.14 In East Indonesia region, Papua, shows PFMSP-1 
gene’s (MAD20) base pairs length variation from 106-255 bp.15 
19 20 21 22 23 DNA 
MARKER 
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Identification result of PFMSP-1 gene in many regions in Indonesia shows gene’s base 
pairs length variations are relatively similar. There are also studies conducted globally to 
identified PFMSP-1 gene with gene’s base pairs length variations. There are Malaysia with 
PFMSP-1 gene’s (MAD20) base pairs length variation range from 180 bp, Myanmar (120-300 
bp), India (175-600 bp), Iran (170-210 bp with seven variations) and Ethiopia (100-300 bp).16–
20 
Based on the results of several studies that have been presented, the base pairs length 
variotion of PFMSP-1 gene with MAD20 alleles ranges from 100-600 bp. Based on this, this 
study supports data from previous studies and has been added in new literature regarding the 
variation in base pairs length of the MAD20 allele from the PFMSP-1 gene. In addition, this 
study is the first genetic data from the PFMSP-1 gene in the Pesawaran, Lampung, which is one 
of the malaria endemic areas. 
Other previous study shows that PFMSP-1 gene is a gene with relatively high base pairs 
length variation proved by different range of base pairs length on each region. PFMSP-1 gene’s 
base pairs length variation increase its genetic variations. Increase genetic variations is affected 
by characteristic of gene’s itself and it’s environment. Study conducted in Maluku, shows that 
there are seven base pairs length variations range from 100 bp to 300 bp in close community 
compared to 12 base pairs length variations range from 100 bp to 500 bp in open community. 
This difference shows that environmental factor can cause genetic variations. Close community 
defined as group of peoples that has minimal contact with environment and chemical substance 
such as drugs. Therefore, close community is less likely to have gene’s mutation. Contrast to 
open community who expose with environmental factors such as interaction between 
individuals and other substances.18,20,21 The location of this research is one of the tourist 
locations in Lampung Province with a high intensity of tourist arrivals. This could be one of the 
factors of the high number of genetic variations in the Hanura region which support by the 
previous study. 
Infection of more than one gene of Plasmodium sp. is called by multigenotipe infection. 
Multigenotip infections of Plasmodium falciparum can increase genetic variations in PFMSP-
1 gene and increase probability of gene recombination in meiotic state of Plasmodium sp. 
Recombination can occur in vector’s body (Anopheles sp.) that bite individuals with 
multigenotype infection. Asexual phase of Plasmodium sp. occur in human body until 
gametocyte is formed, whether its macrogametocyte or microgametocyte. In this condition, 
Anopheles sp. probably takes up blood that contain gametocytes from different kind of 
Anopheles sp. genes. Meiotic recombination will occur at sexual phase in vector's body then 
  Bioscientia Medicina Page 7 
 
causing new genetic variations. Proportion of multigenotype infection and amount of clones 
(Allelic types) per individual are two prerequisite that increase parasite genetic 
diversity.13,18,21,22 
In this study there are more than one variant of PFMSP-1 gene that infected one sample. 
This can occur as a result of multigenotip infection. Multigenotip infection can occur in a region 
with high level of transmission condition. This condition can increase interaction probability 
between another disease that occur in one individual. Location with high level of transmission 
often found in endemic region of Malaria.18,20 This study was conducted in Hanura, Pesawaran, 
Lampung, which is one of the malaria endemic areas with the highest Annual Parasite Incidence 
(API) in Lampung Province, 6.36.3 So with multigenotype infections that have been found and 
included in malaria endemic areas, the incidence of variation genetic makeup of the PFMSP-1 
gene can be increased. 
Along with increased genetic diversity in Plasmodium sp., changes will occur in 
parasite’s body so it can adapt and survive its envionmental condition. One of genetic diversity 
effect is increased incidence of anti malaria drug resistance. This phenomenon is in line with 
study that conducted along west border of Thailand-Myanmar, found that there is lower cure 
rate of artesunate-mefloquine combination therapy in Ranong city compare to other city 
because of its high genetic diversity of PFMSP-1 gene.7  Furthermore, anti malarial drug 
(kloroquin) resistance also reported in India and Indonesia.23,24 The similarity of drugs 
resistance in Indonesia and India can be attributed by genetic factors of Plasmodium falciparum 
in both countries. Genetic similarity in a parasite stimulate the same response to administration 
of a substance, as same as treatment. So, it is necessary to conduct a strict data collection on the 
types of resistance that occur in each region that has genetic similarities in the parasite causing 
the disease, so that the incidence of resistance to a drug can be prevented or handled better. 
Another factors that can increased genetic diversity of Plasmodium sp. are host, vector’s 
population and its environment. Host of malaria is human’s body, level of human immunity is 
the most substantial factor that affecting severity of the disease. The more higher level of 
immunity, defense mechanism of innate immunity against the parasite will also increase. The 
more higher vector’s populations, transmission level and infection number of Plasmodium sp., 
will also increase. Environment as the last factor also has an important role because of its effect 
on enhancing another factors.13 
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Conclusion 
PFMSP-1 gene has successfully amplified from individual’s blood sample infected by 
Malaria in Puskesmas Hanura, Pesawaran, Lampung. 
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